Jazz Pharmaceuticals plc (J7Z) — Financial Flexibility Index
Jazz Pharmaceuticals plc (J7Z) has a Financial Flexibility Index of 0.06x as of March 2026. Free cash flow of €427.90 Million (operating CF €408.20 Million minus capex €19.70 Million) represents 0% of total liabilities (€7.33 Billion). Check J7Z strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jazz Pharmaceuticals plc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Jazz Pharmaceuticals plc across 13 annual periods. See Jazz Pharmaceuticals plc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jazz Pharmaceuticals plc (2013–2025)
Year-by-year free cash flow to debt coverage for Jazz Pharmaceuticals plc. For the full company profile including market capitalisation, see Jazz Pharmaceuticals plc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | €1.57 Billion | €1.36 Billion | €7.34 Billion | ▲ +17.0% |
| 2024 | 0.18x | €1.44 Billion | €1.40 Billion | €7.92 Billion | ▲ +23.0% |
| 2023 | 0.15x | €1.13 Billion | €1.09 Billion | €7.66 Billion | ▼ -11.7% |
| 2022 | 0.17x | €1.30 Billion | €1.27 Billion | €7.75 Billion | ▲ +73.5% |
| 2021 | 0.10x | €806.15 Million | €778.51 Million | €8.33 Billion | ▼ -69.6% |
| 2020 | 0.32x | €914.65 Million | €899.65 Million | €2.88 Billion | ▼ -5.4% |
| 2019 | 0.34x | €816.54 Million | €776.40 Million | €2.43 Billion | ▲ +0.4% |
| 2018 | 0.33x | €819.27 Million | €798.90 Million | €2.45 Billion | ▲ +11.8% |
| 2017 | 0.30x | €722.04 Million | €693.09 Million | €2.41 Billion | ▲ +13.1% |
| 2016 | 0.26x | €773.97 Million | €592.39 Million | €2.92 Billion | ▼ -19.1% |
| 2015 | 0.33x | €567.90 Million | €531.94 Million | €1.73 Billion | ▲ +45.2% |
| 2014 | 0.23x | €443.95 Million | €407.61 Million | €1.97 Billion | ▼ -28.7% |
| 2013 | 0.32x | €298.41 Million | €288.43 Million | €942.69 Million | — |